133 related articles for article (PubMed ID: 20848850)
21. [Polymerase region mutations and hepatitis B virus genotypes in chronic hepatitis B patients with poor response to lamivudine].
Xu LJ; Pan C; Li QG; Chen RH; Zheng L; Zhang QY; Chen HC
Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):180-3. PubMed ID: 20380793
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy.
Yuen MF; Sablon E; Hui CK; Yuan HJ; Decraemer H; Lai CL
Hepatology; 2001 Oct; 34(4 Pt 1):785-91. PubMed ID: 11584376
[TBL] [Abstract][Full Text] [Related]
23. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy.
Chayama K; Suzuki Y; Kobayashi M; Kobayashi M; Tsubota A; Hashimoto M; Miyano Y; Koike H; Kobayashi M; Koida I; Arase Y; Saitoh S; Murashima N; Ikeda K; Kumada H
Hepatology; 1998 Jun; 27(6):1711-6. PubMed ID: 9620347
[TBL] [Abstract][Full Text] [Related]
24. Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.
Enomoto M; Tamori A; Kohmoto MT; Morikawa H; Habu D; Sakaguchi H; Takeda T; Seki S; Kawada N; Shiomi S; Nishiguchi S
J Med Virol; 2007 Nov; 79(11):1664-70. PubMed ID: 17854034
[TBL] [Abstract][Full Text] [Related]
25. YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay.
Akarsu M; Sengonul A; Tankurt E; Sayiner AA; Topalak O; Akpinar H; Abacioglu YH
J Gastroenterol Hepatol; 2006 Dec; 21(12):1783-8. PubMed ID: 17074014
[TBL] [Abstract][Full Text] [Related]
26. The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.
Gwak GY; Huh W; Lee DH; Choi MS; Lee JH; Koh KC; Kim SJ; Joh JW; Oh HY
Transplant Proc; 2007 Dec; 39(10):3121-6. PubMed ID: 18089336
[TBL] [Abstract][Full Text] [Related]
27. [Occurrence and predictive factors of hepatitis B virus polymerase YMDD variation among patients with chronic hepatitis B and liver cirrhosis during lamivudine therapy].
Wang L; Yan J; Zhang ZH; Wang JB; Du YZ; Li XY; Wang YZ
Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):585-8. PubMed ID: 15504286
[TBL] [Abstract][Full Text] [Related]
28. [Detecting significance of HBV-LP in the HBeAg negative patients with chronic hepatitis B].
Shi QF; Wang YP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Apr; 23(2):135-7. PubMed ID: 20104759
[TBL] [Abstract][Full Text] [Related]
29. No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants.
Caccamo L; Romeo R; Rossi G; Maggioni M; Radice F; Lunghi G; Colombo M; Fassati LR
Transpl Int; 2005 Feb; 18(2):186-92. PubMed ID: 15691271
[TBL] [Abstract][Full Text] [Related]
30. [The study of the sensitive and specificity on HBV DNA replication by HBV-lP detecting].
Shan PN; Lu ZY; Xuan GH; Weng LM; Ru JC; Tan SH; Xu DS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):68-70. PubMed ID: 20848857
[TBL] [Abstract][Full Text] [Related]
31. The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B.
Paik YH; Han KH; Hong SP; Lee HW; Lee KS; Kim SO; Shin JE; Ahn SH; Chon CY; Moon YM
Antivir Ther; 2006; 11(4):447-55. PubMed ID: 16856618
[TBL] [Abstract][Full Text] [Related]
32. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo.
Tipples GA; Ma MM; Fischer KP; Bain VG; Kneteman NM; Tyrrell DL
Hepatology; 1996 Sep; 24(3):714-7. PubMed ID: 8781348
[TBL] [Abstract][Full Text] [Related]
33. Comparison of mass spectrometric analysis and TRUGENE HBV genotyping for monitoring lamivudine resistance in chronic hepatitis B patients.
Woo HY; Park H; Kim BI; Jeon WK; Cho YK; Kim YJ
Antivir Ther; 2007; 12(1):7-13. PubMed ID: 17503742
[TBL] [Abstract][Full Text] [Related]
34. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy.
Liaw YF; Chien RN; Yeh CT; Tsai SL; Chu CM
Hepatology; 1999 Aug; 30(2):567-72. PubMed ID: 10421670
[TBL] [Abstract][Full Text] [Related]
35. YMDD mutants in patients with chronic hepatitis B before treatment are not selected by lamivudine.
Matsuda M; Suzuki F; Suzuki Y; Tsubota A; Akuta N; Hosaka T; Someya T; Kobayashi M; Saitoh S; Arase Y; Satoh J; Kobayashi M; Ikeda K; Miyakawa Y; Kumada H
J Med Virol; 2004 Oct; 74(2):361-6. PubMed ID: 15332287
[TBL] [Abstract][Full Text] [Related]
36. A real-time quantitative polymerase chain reaction method for hepatitis B virus in patients with chronic hepatitis B treated with lamivudine.
Ide T; Kumashiro R; Koga Y; Tanaka E; Hino T; Hisamochi A; Murashima S; Ogata K; Tanaka K; Kuwahara R; Sata M
Am J Gastroenterol; 2003 Sep; 98(9):2048-51. PubMed ID: 14499786
[TBL] [Abstract][Full Text] [Related]
37. Genotypic resistance of hepatitis B virus to lamivudine in renal transplant recipients.
Joh JW; Lee HH; Park JW; Lee DH; Yoo BC; Lee KW; Kim SJ
Transplant Proc; 2005 Mar; 37(2):1235-7. PubMed ID: 15848680
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudine.
Amini-Bavil-Olyaee S; Hosseini SY; Sabahi F; Alavian SM
Int J Infect Dis; 2008 Jan; 12(1):83-7. PubMed ID: 17698384
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of dried blood samples for quantification and molecular characterization of HBV-DNA.
Jardi R; Rodriguez-Frias F; Buti M; Schaper M; Valdes A; Martinez M; Esteban R; Guardia J
Hepatology; 2004 Jul; 40(1):133-9. PubMed ID: 15239096
[TBL] [Abstract][Full Text] [Related]
40. [Relationship between core promoter mutation, clinical features and virus replication in HBV carriers].
Dai EH; Liu HJ; Song YJ; Chen CY; Yang RF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):25-7. PubMed ID: 16201466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
